| Post-pimobendan | Post-placebo | P value |
---|---|---|---|
LAFS 2-D4 [median % change (IQR)] | 12.08 (6.25, 17.43) | −5.77 (− 19.75, 3.28) | 0.03 |
Mitral TDI S5 (mean % change ± SD) | 10.76 ± 19.85 | −6.42 ± 23.07 | 0.11 |
LVOT Vmax5 (mean % change ± SD) | 20.08 ± 28.92 | 20.39 ± 31.51 | 0.96 |
RVOT Vmax5 (mean % change ± SD) | 22.6 ± 23.8 | 19.92 ± 10.25 | 0.68 |
HR at LVOT Vmax5 (mean % change ± SD) | 4.67 ± 6.7 | 2.8 ± 12.8 | 0.72 |
HR at RVOT Vmax5 (mean bpm ± SD) | 5.1 ± 12.9 | 6.26 ± 9.30 | 0.80 |